2025

Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. (Wiesman AI. et al., 2025)

Citation : Wiesman, A. I., Madge, V., Fon, E. A., Dagher, A., Collins, D. L., Baillet, S., & PREVENT-AD Research Group and Quebec Parkinson Network (2025). Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. Brain : a journal of neurology, 148(3), 875–885. https://doi.org/10.1093/brain/awae295. Full text : Here Associations between neuromelanin depletion and […]

Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. (Wiesman AI. et al., 2025) Read More »

Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. (Tremblay C. et Al., 2025)

Citation : Tremblay, C., Rahayel, S., Pastor-Bernier, A., St-Onge, F., Vo, A., Rheault, F., Daneault, V., Morys, F., Rajah, N., Villeneuve, S., Dagher, A., PREVENT-AD Research Group , & Alzheimer’s Disease Neuroimaging Initiative (ADNI) (2025). Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. Brain communications, 7(2), fcaf099. https://doi.org/10.1093/braincomms/fcaf099 Full text

Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. (Tremblay C. et Al., 2025) Read More »

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer’s disease. (Walker CS. et al., 2025)

Citation : Walker, C. S., Noriega de la Colina, A. E., Li, L., Boulanger, C., Thovinakere, N., Noly-Gandon, A., Barnoin, G., Bennett, M., Caplan, J., Côté, L., Elbaz, S., Bao, S. F. K., Kara, R., Lavoie, N., Nguyen, M., Otaner, F., Pallett-Wiesel, H., Piché, J. V., Powers, A., Ricciardelli, S., … PREVENT-AD Research Group (2025).

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer’s disease. (Walker CS. et al., 2025) Read More »

Depressive Symptoms and Amyloid Pathology. (Wiels WA. et al., 2025)

Citation : Wiels, W. A., Oomens, J. E., Engelborghs, S., Baeken, C., von Arnim, C. A. F., Boada, M., Didic, M., Dubois, B., Fladby, T., van der Flier, W. M., Frisoni, G. B., Fröhlich, L., Gill, K. D., Grimmer, T., Hildebrandt, H., Hort, J., Itoh, Y., Iwatsubo, T., Klimkowicz-Mrowiec, A., Lee, D. Y., … Zettergren,

Depressive Symptoms and Amyloid Pathology. (Wiels WA. et al., 2025) Read More »

Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window. (Yakoub Y. et Al., 2025)

Citation : Yakoub, Y., Gonzalez-Ortiz, F., Ashton, N. J., Déry, C., Strikwerda-Brown, C., St-Onge, F., Ourry, V., Schöll, M., Geddes, M. R., Ducharme, S., Montembeault, M., Rosa-Neto, P., Soucy, J. P., Breitner, J. C. S., Zetterberg, H., Blennow, K., Poirier, J., Villeneuve, S., & PREVENT−AD Research Group (2025). Plasma p-tau217 identifies cognitively normal older adults

Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window. (Yakoub Y. et Al., 2025) Read More »

Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE 4 Carriers. (Fisher L., et al., 2025)

Citation : Fischer, L., Molloy, E. N., Pichet Binette, A., Vockert, N., Marquardt, J., Pacha Pilar, A., Kreissl, M. C., Remz, J., Tremblay-Mercier, J., Poirier, J., Rajah, M. N., Villeneuve, S., PREVENT-AD Research Group, & Maass, A. (2025). Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE4 Carriers. The

Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE 4 Carriers. (Fisher L., et al., 2025) Read More »

Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease. (Ao J. et Al., 2025)

Citation : Ao, J., Picard, C., Auld, D., Zetterberg, H., Brinkmalm, A., Blennow, K., Villeneuve, S., Breitner, J. C. S., Poirier, J., & PREVENT-AD research group (2025). Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease. Molecular psychiatry, 10.1038/s41380-024-02884-z. Advance online publication. https://doi.org/10.1038/s41380-024-02884-z Full text

Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease. (Ao J. et Al., 2025) Read More »

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer’s disease. (Walker et al., 2025)

Citation : Walker, C. S., Noriega de la Colina, A. E., Li, L., Boulanger, C., Thovinakere, N., Noly-Gandon, A., Barnoin, G., Bennett, M., Caplan, J., Côté, L., Elbaz, S., Bao, S. F. K., Kara, R., Lavoie, N., Nguyen, M., Otaner, F., Pallett-Wiesel, H., Piché, J. V., Powers, A., Ricciardelli, S., … PREVENT-AD Research Group (2025).

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer’s disease. (Walker et al., 2025) Read More »